fluorodeoxyglucose f18 has been researched along with iopamidol in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (41.18) | 29.6817 |
| 2010's | 9 (52.94) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, WS; Chu, SK; Coel, M; Tam, YM; Vernon, P; Wong, S; Yau, YY | 1 |
| Cho, EY; Chong, S; Kim, BT; Kim, TS | 1 |
| An, YS; Hwang, SC; Oh, YJ; Sheen, SS; Yoon, JK | 1 |
| Domeki, Y; Fukasawa, I; Inaba, N; Kaji, Y; Kitajima, K; Murakami, K; Suganuma, N; Sugimura, K; Yamasaki, E | 1 |
| Badiee, S; Chu, B; Coakley, F; Franc, BL; Hawkins, RA; Singer, L; Webb, EM | 1 |
| Hosono, M; Kumano, S; Kuwabara, M; Murakami, T; Okada, M; Shimono, T; Shiozaki, H | 1 |
| Aikawa, E; Figueiredo, JL; Hembrador, S; Keliher, E; Kelly, K; Libby, P; Nahrendorf, M; Panizzi, P; Weissleder, R; Zhang, H | 1 |
| Digumarthy, SR; Kalra, MK; Prakash, P; Sharma, A; Shepard, JA | 1 |
| Avril, A; Brouste, V; Cannella, M; Descat, E; Ferron, S; Fonck, M; Gómez, F; Palussière, J | 1 |
| Brady, TJ; Cury, RC; Figueroa, AL; Gardecki, JA; Hoffmann, U; Subramanian, SS; Tawakol, A; Tearney, GJ; Truong, QA | 1 |
| Bakhshi, S; Dhawan, D; Kumar, R; Malhotra, A; Radhakrishnan, V; Sharma, P; Thulkar, S; Vishnubhatla, S | 1 |
| Blake, MA; Boland, GW; Cronin, CG; Daniels, GH; Halpern, EF; Kalra, MK; Palmer, EL; Prakash, P | 1 |
| Domínguez Ferreras, E; García Vicente, AM; Jiménez Aragón, F; Molino Trinidad, C; Pineda Pineda, MD; Poblete García, VM; Sánchez Pérez, V; Soriano Castrejón, Á; Villa Guzmán, JC | 1 |
| Blickman, JG; Maffione, AM; Rampin, L; Rubello, D | 1 |
| Buresta, T; D'Andrea, A; Gravante, S; Palumbo, B; Palumbo, I; Pierotti, L; Scialpi, M | 1 |
| Barina, AR; Bashir, MR; Hanks, BA; Howard, BA; Jaffe, TA; Salama, AK | 1 |
| Handra-Luca, A | 1 |
2 trial(s) available for fluorodeoxyglucose f18 and iopamidol
| Article | Year |
|---|---|
Application of intravenous contrast in PET/CT: does it really introduce significant attenuation correction error?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Artifacts; Contrast Media; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Injections, Intravenous; Iopamidol; Male; Middle Aged; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2005 |
Response assessment of colorectal liver metastases with contrast enhanced CT/18F-FDG PET.
Topics: Adult; Aged; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Iopamidol; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Spain; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
15 other study(ies) available for fluorodeoxyglucose f18 and iopamidol
| Article | Year |
|---|---|
Fibrosing mediastinitis mimicking malignancy at CT: negative FDG uptake in integrated FDG PET/CT imaging.
Topics: Adult; Biopsy; Contrast Media; Diagnosis, Differential; Fibrosis; Fluorodeoxyglucose F18; Humans; Iopamidol; Male; Mediastinal Neoplasms; Mediastinitis; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2007 |
Nonionic intravenous contrast agent does not cause clinically significant artifacts to 18F-FDG PET/CT in patients with lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Artifacts; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Iopamidol; Lung; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed | 2007 |
Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent ovarian cancer: comparison with integrated FDG-PET/non-contrast-enhanced CT and enhanced CT.
Topics: Adult; Aged; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Iopamidol; Male; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Systems Integration; Tomography, X-Ray Computed | 2008 |
Role of IV iodinated contrast material in 18F-FDG PET/CT of liver metastases.
Topics: Colorectal Neoplasms; Contrast Media; Fluorodeoxyglucose F18; Image Enhancement; Iopamidol; Liver Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Integrated FDG-PET/CT compared with intravenous contrast-enhanced CT for evaluation of metastatic regional lymph nodes in patients with resectable early stage esophageal cancer.
Topics: Aged; Contrast Media; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Injections, Intravenous; Iopamidol; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Systems Integration; Tomography, X-Ray Computed | 2009 |
18F-4V for PET-CT imaging of VCAM-1 expression in atherosclerosis.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Atorvastatin; Binding, Competitive; Cells, Cultured; Contrast Media; Disease Models, Animal; Endothelium, Vascular; Feasibility Studies; Fluorodeoxyglucose F18; Graft Rejection; Half-Life; Heart Transplantation; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Inflammation Mediators; Iopamidol; Ligands; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Myocardial Infarction; Peptides; Positron-Emission Tomography; Predictive Value of Tests; Pyrroles; Radiopharmaceuticals; Reproducibility of Results; RNA, Messenger; Tissue Distribution; Tomography, X-Ray Computed; Vascular Cell Adhesion Molecule-1 | 2009 |
FDG PET/CT in assessment of pulmonary lymphangitic carcinomatosis.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Iopamidol; Lung Neoplasms; Lymphangitis; Male; Middle Aged; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Sensitivity and Specificity | 2010 |
Single-session radiofrequency ablation of bilateral lung metastases.
Topics: Adult; Aged; Aged, 80 and over; Catheter Ablation; Contrast Media; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Iohexol; Iopamidol; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiography, Interventional; Radiopharmaceuticals; Retreatment; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed | 2012 |
Distribution of inflammation within carotid atherosclerotic plaques with high-risk morphological features: a comparison between positron emission tomography activity, plaque morphology, and histopathology.
Topics: Aged; Atherosclerosis; Carotid Stenosis; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Iopamidol; Male; Middle Aged; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals; Risk Factors; Tomography, X-Ray Computed | 2012 |
Pediatric nonlymphoblastic non-Hodgkin lymphoma: baseline, interim, and posttreatment PET/CT versus contrast-enhanced CT for evaluation--a prospective study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Contrast Media; Diatrizoate; Female; Fluorodeoxyglucose F18; Humans; Iopamidol; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Male; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Brown fat at PET/CT: correlation with patient characteristics.
Topics: Adipose Tissue, Brown; Analysis of Variance; Barium Sulfate; Case-Control Studies; Chi-Square Distribution; Female; Fluorodeoxyglucose F18; Humans; Iopamidol; Male; Multimodal Imaging; Neoplasms; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Sex Factors; Tomography, X-Ray Computed | 2012 |
Invited editorial: Response to therapy assessment of colorectal liver metastasis.
Topics: Adult; Aged; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Iopamidol; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Spain; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
FDG PET and Split-Bolus Multi-Detector Row CT Fusion Imaging in Oncologic Patients: Preliminary Results.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Iohexol; Iopamidol; Male; Middle Aged; Multidetector Computed Tomography; Multimodal Imaging; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2016 |
Isolated recto-sigmoid colitis: a new imaging pattern of ipilimumab-associated colitis.
Topics: Aged; Antibodies, Monoclonal; Colitis; Colon, Sigmoid; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Iopamidol; Ipilimumab; Male; Melanoma; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2016 |
Xanthomatous Interstitial Pneumopathy: Chemotherapy- or Contrast Substance Related Change?
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Iopamidol; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Pneumonectomy; Positron-Emission Tomography; Xanthomatosis | 2020 |